Bayzed Health Group (HKSE:02609) EBITDA per Share: HK$0.03 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02609 Bayzed Health Group Inc HKSE:02609
12 GF Score
Price HK$2.99
! 2 Warning Signs
View Full Analysis

What is Bayzed Health Group EBITDA per Share?

Bayzed Health Group HKSE:02609 -1.81% 12 EBITDA per Share is HK$0.03 as of Dec. 2025. GuruFocus rates HKSE:02609 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Bayzed Health Group ranks better than 91.25% on this metric.

Bayzed Health Group's EBITDA per Share for the six months ended in Dec. 2025 was HK$0.03. Its EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.03.

During the past 12 months, the average EBITDA per Share Growth Rate of Bayzed Health Group was 8.10% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 52.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Bayzed Health Group's EBITDA per Share or its related term are showing as below:

HKSE:02609' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 52.8   Med: 70.2   Max: 87.6
Current: 52.8

During the past 5 years, the highest 3-Year average EBITDA per Share Growth Rate of Bayzed Health Group was 87.60% per year. The lowest was 52.80% per year. And the median was 70.20% per year.

HKSE:02609's 3-Year EBITDA Growth Rate is ranked better than
91.25% of 526 companies
in the Healthcare Providers & Services industry
Industry Median: 10.2 vs HKSE:02609: 52.80

Bayzed Health Group's EBITDA for the six months ended in Dec. 2025 was HK$34 Mil.

During the past 12 months, the average EBITDA Growth Rate of Bayzed Health Group was 3.10% per year. During the past 3 years, the average EBITDA Growth Rate was 50.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 5 years, the highest 3-Year average EBITDA Growth Rate of Bayzed Health Group was 86.40% per year. The lowest was 50.10% per year. And the median was 68.25% per year.


Bayzed Health Group  (HKSE:02609) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Bayzed Health Group EBITDA per Share Related Terms


Bayzed Health Group EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Bayzed Health Group's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayzed Health Group EBITDA per Share Chart

Bayzed Health Group Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA per Share
0.02 0.03 0.09 0.10 0.11

Bayzed Health Group Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA per Share Get a 7-Day Free Trial 0.05 0.01 0.02 0.00 0.03
HKSE:02609
12GF Score
Bayzed Health Group Inc HKSE:02609
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayzed Health Group EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Bayzed Health Group's EBITDA per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA per Share(A: Dec. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=134.487/1255.378
=0.11

Bayzed Health Group's EBITDA per Share for the quarter that ended in Dec. 2025 is calculated as

EBITDA per Share(Q: Dec. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=33.565/1192.290
=0.03

EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of HK$0.03 mean?
Bayzed Health Group (HKSE:02609) has a EBITDA per Share of HK$0.03 as of Dec. 2025. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Bayzed Health Group and its competitors. According to the industry distribution chart, Bayzed Health Group ranks #46 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 8.7%.
Is Bayzed Health Group's EBITDA per Share too high?
Bayzed Health Group's current EBITDA per Share is HK$0.03. Based on the distribution chart, Bayzed Health Group ranks #46 out of 526 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Bayzed Health Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bayzed Health Group's EBITDA per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bayzed Health Group ranks #46 out of 526 companies for EBITDA per Share. This places Bayzed Health Group in the top 9% of its industry — outperforming the majority of peers. The industry median EBITDA per Share is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Healthcare Providers & Services company?
The median EBITDA per Share among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Bayzed Health Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA per Share is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayzed Health Group's current EBITDA per Share is HK$0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayzed Health Group stock overvalued right now?
Bayzed Health Group (HKSE:02609) has a current EBITDA per Share of HK$0.03. The current EBITDA per Share is HK$0.03. Bayzed Health Group's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Bayzed Health Group (HKSE:02609), the current EBITDA per Share is HK$0.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bayzed Health Group Business Description

Address No. 16 Lize Road, Room 2401, Mingfeng Tower Office Building, Fengtai District, Beijing, CHN
Bayzed Health Group Inc is an oncology healthcare group that principally engages in the investment in, and provision of, medical and healthcare related services in the PRC. It operates and manages a network of eight hospitals in Beijing, Tianjin, Shanxi Province, Anhui Province, and Henan Province, with a strategic focus on the provision of full-cycle oncology healthcare services through its direct ownership of the equity interest in six private for-profit hospitals and management over two private not-for-profit hospitals.
12GF Score

Get the complete analysis for HKSE:02609

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.99
Price